TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Antibody Testing Market – By Products
1.3.2 Antibody Testing Market – By Indication
1.3.3 Antibody Testing Market – By End User
1.3.4 North America Antibody Testing Market – By Country
2. North America Antibody Testing Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Antibody Testing Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Expert Opinions
5. North America Antibody Testing Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Number of COVID-19 Cases
5.1.2 Increasing Prevalence of Chronic Diseases
5.1.3 Growing Geriatric Population
5.2 Market Restraints
5.2.1 Limitations of Antibody Screening Tests
5.3 Market Opportunities
5.3.1 Collaborative & Innovation-Driven Strategies
5.3.2 Growth of Healthcare Sector in Emerging Markets
5.4 Future Trends
5.4.1 Increasing Adoption and Popularity of Automation in Clinical Laboratories
5.5 Impact Analysis
6. Antibody Testing Market – North America Analysis
6.1 North America Antibody Testing Marker Revenue Forecast and Analysis
7. North America Antibody Testing Market Analysis and Forecasts to 2028 Product
7.1 Overview
7.2 North America Antibody Testing, by Products, 2021 & 2028 (% Share)
7.3 Kits
7.3.1 Overview
7.3.2 Kits: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)
7.3.2.1 Serological Test Kits
7.3.2.1.1 Overview
7.3.2.1.2 Serological Test Kits: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)
7.3.2.2 Immunoglobulin Kits
7.3.2.2.1 Overview
7.3.2.2.2 Immunoglobulin Kits: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)
7.3.2.3 Lateral Flow Assay Kits
7.3.2.3.1 Overview
7.3.2.3.2 Lateral Flow Assay Kits: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)
7.4 Chemical and Reagents
7.4.1 Overview
7.4.2 North America Chemical and Reagents Market Revenue and Forecast to 2028 (USD Million)
7.5 Consumables
7.5.1 Overview
7.5.2 North America Consumables Market Revenue and Forecast to 2028 (USD Million)
8. North America Antibody Testing Market Analysis – By Indication
8.1 Overview
8.2 North America Antibody Testing Market Revenue Share, by Indication (2021 and 2028)
8.3 Infectious Diseases
8.3.1 Overview
8.3.2 Infectious Diseases: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)
8.3.2.1 Covid-19
8.3.2.1.1 Overview
8.3.2.1.2 Covid-19: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)
8.3.2.2 HIV
8.3.2.2.1 Overview
8.3.2.2.2 HIV: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)
8.3.2.3 Hepatitis
8.3.2.3.1 Overview
8.3.2.3.2 Hepatitis: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)
8.3.2.4 Tuberculosis
8.3.2.4.1 Overview
8.3.2.4.2 Tuberculosis: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)
8.3.2.5 Influenza
8.3.2.5.1 Overview
8.3.2.5.2 Influenza: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)
8.3.2.6 Human Papillomavirus (HPV)
8.3.2.6.1 Overview
8.3.2.6.2 Human Papillomavirus (HPV): Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)
8.3.2.7 Others
8.3.2.7.1 Overview
8.3.2.7.2 Others: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)
8.4 Endocrine Diseases
8.4.1 Overview
8.4.2 Endocrine Diseases: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)
8.4.2.1 Diabetes
8.4.2.1.1 Overview
8.4.2.1.2 Diabetes: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)
8.4.2.2 Thyroid Disorders
8.4.2.2.1 Overview
8.4.2.2.2 Thyroid Disorders: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)
8.4.2.3 Others
8.4.2.3.1 Overview
8.4.2.3.2 Others: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)
8.5 Oncology
8.5.1 Overview
8.5.2 Oncology: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)
8.5.2.1 Breast Cancer
8.5.2.1.1 Overview
8.5.2.1.2 Breast Cancer: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)
8.5.2.2 Melanoma
8.5.2.2.1 Overview
8.5.2.2.2 Melanoma: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)
8.5.2.3 Gastric Cancer
8.5.2.3.1 Overview
8.5.2.3.2 Gastric Cancer: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)
8.5.2.4 Others
8.5.2.4.1 Overview
8.5.2.4.2 Others: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)
8.6 Cardiovascular Diseases
8.6.1 Overview
8.6.2 Cardiovascular Diseases: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)
8.7 Pregnancy
8.7.1 Overview
8.7.2 Pregnancy: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)
8.8 Autoimmune Diseases
8.8.1 Overview
8.8.2 Autoimmune Diseases: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)
8.8.2.1 Rheumatoid Arthritis
8.8.2.1.1 Overview
8.8.2.1.2 Rheumatoid Arthritis: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)
8.8.2.2 Inflammatory Bowel Disease
8.8.2.2.1 Overview
8.8.2.2.2 Inflammatory Bowel Disease: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)
8.8.2.3 Multiple Sclerosis
8.8.2.3.1 Overview
8.8.2.3.2 Multiple Sclerosis: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)
8.8.2.4 Others
8.8.2.4.1 Overview
8.8.2.4.2 Others: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)
8.9 Other Diseases
8.9.1 Overview
8.9.2 Other Diseases: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)
9. North America Antibody Testing Market – By End User
9.1 Overview
9.2 Antibody Testing Market, by End User, 2021 and 2028 (%)
9.3 Diagnostic Laboratories
9.3.1 Overview
9.3.2 North America Diagnostic Laboratories Market Revenue and Forecast to 2028 (USD Million)
9.4 Hospitals
9.4.1 Overview
9.4.2 North America Hospitals Market Revenue and Forecast to 2028 (USD Million)
9.5 Biopharmaceutical Companies
9.5.1 Overview
9.5.2 North America Biopharmaceutical Companies: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)
9.6 Academic and Research Institutes
9.6.1 Overview
9.6.2 North America, Academic and Research Institutes: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)
10. North America Antibody Testing Market Analysis and Forecasts To 2028 Country Analysis
10.1 North America: Antibody Testing Market
10.1.1 Overview
10.1.2 North America: Antibody Testing Market, by Country, 2021 & 2028 (%)
10.1.2.1 US: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.1 US: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.2 US: Antibody Testing Market, by Products – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.2.1 US: Antibody Testing Market, by Kits – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.3 US: Antibody Testing Market, by Indication – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.3.1 US: Antibody Testing Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.3.2 US: Antibody Testing Market, by Endocrine Diseases – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.3.3 US: Antibody Testing Market, by Oncology – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.3.4 US: Antibody Testing Market, by Autoimmune Diseases – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.4 US: Antibody Testing Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.1.2.2 Canada: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.1 Canada: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.2 Canada: Antibody Testing Market, by Products – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.2.1 Canada: Antibody Testing Market, by Kits – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.3 Canada: Antibody Testing Market, by Indication – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.3.1 Canada: Antibody Testing Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.3.2 Canada: Antibody Testing Market, by Endocrine Diseases – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.3.3 Canada: Antibody Testing Market, by Oncology – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.3.4 Canada: Antibody Testing Market, by Autoimmune Diseases – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.4 Canada: Antibody Testing Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.1.2.3 Mexico: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.1 Mexico: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.2 Mexico: Antibody Testing Market, by Products – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.2.1 Mexico: Antibody Testing Market, by Kits – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.3 Mexico: Antibody Testing Market, by Indication – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.3.1 Mexico: Antibody Testing Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.3.2 Mexico: Antibody Testing Market, by Endocrine Diseases – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.3.3 Mexico: Antibody Testing Market, by Oncology – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.3.4 Mexico: Antibody Testing Market, by Autoimmune Diseases – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.4 Mexico: Antibody Testing Market, by End User – Revenue and Forecast to 2028 (USD Million)
11. North America Industry Landscape
11.1 Overview
11.2 Growth Strategies Done by the Companies in the Market, (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview
12. Company Profiles
12.1 THERMO FISHER SCIENTIFIC INC.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Abbott
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 BIO-RAD LABORATORIES INC.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 BD
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 F. HOFFMANN-LA ROCHE LTD.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Agilent Technologies, Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 DiaSorin S.p.A.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 ZEUS Scientific
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Abcam plc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Trinity Biotech
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES.
Table 1. Total Number of Persons Aged 60 Years or Above – by Country, 2017 & 2050
Table 2. US: Antibody Testing Market, by Products – Revenue and Forecast to 2028 (USD Million)
Table 3. US: Antibody Testing Market, by Kits – Revenue and Forecast to 2028 (USD Million)
Table 4. US: Antibody Testing Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 5. US: Antibody Testing Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)
Table 6. US: Antibody Testing Market, by Endocrine Diseases – Revenue and Forecast to 2028 (USD Million)
Table 7. US: Antibody Testing Market, by Oncology – Revenue and Forecast to 2028 (USD Million)
Table 8. US: Antibody Testing Market, by Autoimmune Diseases – Revenue and Forecast to 2028 (USD Million)
Table 9. US: Antibody Testing Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 10. Canada: Antibody Testing Market, by Products – Revenue and Forecast to 2028 (USD Million)
Table 11. Canada: Antibody Testing Market, by Kits – Revenue and Forecast to 2028 (USD Million)
Table 12. Canada: Antibody Testing Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 13. Canada: Antibody Testing Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)
Table 14. Canada: Antibody Testing Market, by Endocrine Diseases – Revenue and Forecast to 2028 (USD Million)
Table 15. Canada: Antibody Testing Market, by Oncology – Revenue and Forecast to 2028 (USD Million)
Table 16. Canada: Antibody Testing Market, by Autoimmune Diseases – Revenue and Forecast to 2028 (USD Million)
Table 17. Canada: Antibody Testing Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 18. Mexico: Antibody Testing Market, by Products – Revenue and Forecast to 2028 (USD Million)
Table 19. Mexico: Antibody Testing Market, by Kits – Revenue and Forecast to 2028 (USD Million)
Table 20. Mexico: Antibody Testing Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 21. Mexico: Antibody Testing Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)
Table 22. Mexico: Antibody Testing Market, by Endocrine Diseases – Revenue and Forecast to 2028 (USD Million)
Table 23. Mexico: Antibody Testing Market, by Oncology – Revenue and Forecast to 2028 (USD Million)
Table 24. Mexico: Antibody Testing Market, by Autoimmune Diseases – Revenue and Forecast to 2028 (USD Million)
Table 25. Mexico: Antibody Testing Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 26. Organic Developments Done By Companies
Table 27. Inorganic Developments Done By Companies
Table 28. Glossary of Terms, North America Antibody Testing Market